The Dermatology therapeutics market is growing at a rapid pace
An in-depth Assessment of the Top Drugs Launched by Leading Global Companies in the First Half of 2021 (H1)
medtech-news-for-zynex-foldax-bd-ge-edwards
Sky Medical’s Geko™ device; Fi...

Sky receives FDA clearance to market the geko™ device for venous insufficiency and ischemia  On...

Fda-Approved-Top-Drugs-Launched-in-2021
An in-depth Assessment of the Top Dru...

Progress is driven by innovation. When it comes to developing novel medications and therapeutic biological ...

medtech-news-for-naviswiss-allosource-spinafx-starfish-smith-nephew
FDA 510k clearance to Naviswiss’...

Naviswiss secures FDA 510k clearance for Naviplan, an advanced planning solution for hip replacement surger...

companies-in-gene-therapy-for-dermatology
Analyzing the Key Companies and the Emerging Gene Therapy in the Dermatology Segment

Advances in genetics research have sparked a surge in interest in gene therapy in dermatology in recent years. Dermatology treatment options have expanded beyond topical drugs to include oral medi...


gene-therapies-in-dermatology
Development of Gene Therapies in Dermatology

What is Gene Therapy and Is the Skin Suitable for Gene Therapy? Since its first discovery, conceptualization in 1972, and successful application in 1990 by W. French Anderson, gene therapy has ...


recent-biotech-pharma-news-for-brickell-bms-amydis-gensight-cybrexa
Brickell to Submit New Drug Application to FDA; Twin Health Raises $140M; BMS’ Deucravaciti...

Brickell Plans to Submit New Drug Application to FDA for gel Brickell Biotech will request the FDA in mid-2022 to approve its gel for excessive underarm sweating after decreasing sweat producti...


pharma-biotech-news-updates-for-innovent-biohaven-delix-intracellular-therapies
UNION Therapeutics-Innovent’s collaboration; Delix Therapeutics bags $ 70 M; Biohaven’s Ver...

Innovent, UNION Therapeutics Set to Advance Dermatology Market in China  Innovent Biologics and UNION therapeutics have announced a strategic and licensing collaboration to develop and com...


latest-biotech-healthcare-pharma-news-updates-aelis-farma-alcyone-progentec-gsk-kozin
Aelis Farma pockets $30M; Alcyone unveils $23M for AAV gene therapies; Progentec and GSK collabor...

Aelis Farma pockets USD 30 Million upfront in cannabis use disorder deal with Indivior Indivior speculates that Aelis Farma has what it takes to bring cannabis use disorder therapy into the cli...


absssi-pipeline-analysis
Pharma Companies Foray into the ABSSSI Market to Develop Novel Antibiotics and Tackle Antibiotic ...

The introduction of antibiotics subsequently transformed the healthcare industry bringing on the table several life-saving drugs. Long 60 years back, when the first antibiotic, Penicillin, came in...


Editor's Pick
22 Healthcare Trends & Innovations to Watch in 2022 and Beyond

With the advent of new-age healthcare industry trends that are evident as of now, there...

Assessment of Key Products that Got FDA Approval in Second Half (H2) of 2021

Although COVID-19 continued to dominate headlines in 2021, pharmaceutical companies did...

Analyzing the Key Trends Driving the Biosimilar Market Growth

The Biosimilars market is growing at a breakneck pace. The biosimilar market provides a...

CAR-T Cell Therapy aka Miraculous Technology: Mapping the Market, Approved Th...

Chimeric antigen receptor T-cell (CAR T) therapies are shown to have transformative pot...

Myelodysplastic Syndromes (MDS): Key Pharma Players Unveiling Updated Finding...

There has been limited progress in the approval of novel agents in MDS. It has been a l...